Novel cholesterol removal strategy shows potential benefits post-heart attack

Cholesterol News

Novel cholesterol removal strategy shows potential benefits post-heart attack
HeartBloodBlood Clot
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 56 sec. here
  • 13 min. at publisher
  • 📊 Quality Score:
  • News: 64%
  • Publisher: 71%

The first trial of a novel strategy for removing cholesterol from patients' arteries did not reduce the risk of death, heart attack or stroke within three months of a prior heart attack, according to research presented at the American College of Cardiology's Annual Scientific Session.

Apr 8 2024American College of Cardiology The first trial of a novel strategy for removing cholesterol from patients' arteries did not reduce the risk of death, heart attack or stroke within three months of a prior heart attack , according to research presented at the American College of Cardiology 's Annual Scientific Session. However, the findings suggest that the strategy may be beneficial with longer follow-up.

People who have had a heart attack are at high risk for another one, especially during the next 90 days, Gibson said. This study was the first in which patients received an infusion of ApoA-I, a component of HDL cholesterol, shortly after a heart attack, with the aim of stabilizing coronary plaque and reducing adverse cardiovascular events. The investigational drug CSL112 used in the study is a form of ApoA-I that's extracted from human plasma, the liquid component of blood.

"We know that in the setting of a heart attack, when the HDL cholesterol is good at getting a lot of cholesterol out of the arteries, that results in better outcomes for patients," he said. The study's primary endpoint was the time to the first occurrence of a major adverse cardiovascular event at 90 days. Secondary endpoints included the time to the first occurrence of a MACE within six months and one year and of each specific event within 90 days, six months and one year.

Future research will focus on identifying high-risk patients who might benefit from this approach, he said.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NewsMedical /  🏆 19. in UK

Heart Blood Blood Clot Cardiology Heart Attack Medical School Medicine Placebo Research Stent Stroke

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Potential novel biomarkers of coronary heart disease discoveredPotential novel biomarkers of coronary heart disease discoveredCoronary heart disease (CHD) is one of the most common causes of death worldwide—especially in Europe: Here, it is responsible for nearly half of all deaths. Among middle-aged adults, individuals with type 2 diabetes (T2D) have a two to four times higher risk of developing CHD than people without T2D.
Read more »

Study shows improved outcomes in hospitals accredited for rectal cancer surgeryStudy shows improved outcomes in hospitals accredited for rectal cancer surgeryHospitals accredited by the American College of Surgeons (ACS) National Accreditation Program for Rectal Cancer (NAPRC) demonstrate significantly better outcomes for patients undergoing rectal cancer surgery compared to non-accredited hospitals, according to a new study published in the Journal of the American College of Surgeons.
Read more »

Unfavorable Social Factors and Heart Disease Risk in Asian American AdultsUnfavorable Social Factors and Heart Disease Risk in Asian American AdultsA recent study suggests that unfavorable social factors can increase the risk of heart disease in Asian American adults.
Read more »

Novel protective antibody target identified against Crimean-Congo hemorrhagic fever virusNovel protective antibody target identified against Crimean-Congo hemorrhagic fever virusA research team led by the United States Army Medical Research Institute of Infectious Diseases, or USAMRIID, that includes Scott Pegan at the UC Riverside School of Medicine has discovered an important protective antibody target against Crimean-Congo hemorrhagic fever virus, or CCHFV.
Read more »

Novel study compares fracture patterning in fatal, survived intimate partner violence casesNovel study compares fracture patterning in fatal, survived intimate partner violence casesIntimate partner violence (IPV) is an underreported global human rights issue that affects approximately 25% of women and 10% of men and is the leading cause of homicides among women worldwide. Multiple interventional studies have been conducted to screen for IPV.
Read more »

Interview with Bradford author Sairish Hussain about her new novel Hidden FiresInterview with Bradford author Sairish Hussain about her new novel Hidden FiresIn February 2020, Bradford author Sairish Hussain’s debut novel The Family Tree was published. An affecting, engaging multi-generational story about a British Muslim family living in the North of England, it was full of insight, warmth and humour and rightly received much acclaim from critics and readers alike.
Read more »



Render Time: 2025-02-15 08:44:34